What is an Implantable Cardioverter Defibrillator (ICD)?

An ICD is a medical device implanted in the chest to monitor and treat life-threatening arrhythmias by delivering electric shocks to restore a normal heart rhythm.

How big is the Implantable Cardioverter Defibrillator Market?

The global Implantable Cardioverter Defibrillator Market size was estimated at USD 4.1 billion in 2022 and is expected to reach USD 7.7 billion in 2032.

What is the Implantable Cardioverter Defibrillator Market growth?

The global Implantable Cardioverter Defibrillator Market is expected to grow at a compound annual growth rate of 6.5%. From 2023 To 2032

Who are the key companies/players in the Implantable Cardioverter Defibrillator Market?

Some of the key players in the Implantable Cardioverter Defibrillator Markets are ZOLL Medical Corporation, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, Medtronic PLC, Jude Medical, Koninklijke Philips N.V., Sorin Group, Nohen Kohden Corporation, LivaNova PLC, Fukuda Denshi Co. Ltd., Mediana Co. Ltd., Element Science Inc., Stryker Corporation, Other key players

Who needs an Implantable Cardioverter Defibrillator ?

ICDs are typically recommended for individuals at high risk of sudden cardiac arrest due to certain heart conditions, such as ventricular arrhythmias.

How does an ICD work?

It continuously monitors the heart's rhythm and delivers a shock if it detects a dangerous arrhythmia, restoring the heart's normal rhythm.

What are the key players in the ICD market?

Major companies in the ICD market include Medtronic, Abbott Laboratories, Boston Scientific, and Biotronik, among others.

Global Implantable Cardioverter Defibrillator Market By Type (Subcutaneous Cardioverter Defibrillator (S-ICDs), Transvenous Cardioverter Defibrillator (T-ICDs), and Other), By Application (Hospitals, Clinics, and Ambulatory Surgical Centers), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2023-2032

Published date: Oct 2023
Report ID: 106466
Number of Pages: 260
Format:

- ZOLL Medical Corporation
- Boston Scientific Corporation Company Profile
- BIOTRONIK SE & Co. KG
- Medtronic PLC
- Jude Medical
- Koninklijke Philips N.V.
- Sorin Group
- Nohen Kohden Corporation
- LivaNova PLC
- Fukuda Denshi Co. Ltd.
- Mediana Co. Ltd.
- Element Science Inc.
- Stryker Corporation Company Profile
- Other key players
Settings

Related Reports

Our Clients

Inquiry Before Buying

Implantable Cardioverter Defibrillator Market

Report ID 106466
Published Date Oct 2023
Rating
- ★★★★★
  
  ★★★★★
- (89)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)